Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Preparing for a GMP inspection takes more than updated documents. Discover how pharma consultancy in Kolkata helps manufacturers address compliance gaps, strengthen quality systems, meet revised Schedule M requirements, and build reliable evidence for CDSCO inspections.
European regulators have revoked Tavneos’ marketing authorization in the EU and EEA after finding serious problems in how data from its pivotal ADVOCATE study were handled. The EMA concluded that the study could no longer reliably demonstrate efficacy after unblinded
Novo Nordisk filed a federal lawsuit against Eli Lilly in New Jersey on July 21, 2026, accusing the company of misleading consumers through national advertising for Zepbound and Mounjaro. Novo claims Lilly compared its highest drug doses with lower doses